Covid-19 – Day 125: Giving Oxygene to Covid-19 Patients
(E) The arenicola marina (or lugworm or sandworm) has a blood structure that is comparable to human hemoglobin but according to Hemarina, a French biotech start-up, it differs in three […]
Covid-19 – Day 125: 2020 Covid-19 Recession = No Cash Flows + Furlough + Layoffs
(E) The 2020 Covid-19 Recession = No Cash Flows + Furlough + Layoffs. Companies, and in particular small businesses, that have no cash on their balance sheets are suffering, and […]
Covid-19 – Day 135: Johnson & Johnson Vaccine against the SARS-CoV-2
(E) Johnson & Johnson has just announced, that in partnership with the US federal government, it will invest more than $1 billion in a potential vaccine, developed at the Beth […]
Covid-19 – Day 134: The Evolution of the SARS-CoV-2 and Why it is so Destructive to the Human Body?
(E) Two excellent articles, well detailed and can be understood by everyone. In the New Yorker: “From Bats to Human Lungs, the Evolution of a Coronavirus” , and in the […]
Covid-19 – Day 133: Visualizing the Pandemic
(E) While everyone is familiar with the excellent Johns Hopkins University’s visualization too of worldwide and per country Covid-19 cases, the Institute for Health Metrics and Evaluation (IHME) part of […]
Covid-19 – Day 129: Comparing the 1918 Spanish Flu to the Coronavirus of 2020
(E) The New Yorker interviewed John Barry, the author of “The Great Influenza” and an expert on the Spanish flu pandemic. He explains, in the following video, the parallel between […]
Covid-19 – Day 128: A Simple Explanation of why the Soap Kills the SARS CoV-2
(E) Easy, fast, and useful to read, published in Le Monde: Comment le savon permet de détruire le coronavirus? Note: The picture above is un savon de Marseilles. Copyright © […]
Covid-19 – Day 128: Mount Sinai to Begin the Transfer of COVID-19 Antibodies into Critically Ill Patients
(E) We know for sure that transferring antibodies from health patients to critically ill ones should work. Mount Sinai Hospital, based in New York, is working on it: Mount Sinai […]
Covid-19 – Day 127: Modeling the Exponential Covid-19 Epidemic Growth Rate
(E) Modeling the epidemy – from understanding the basic math of what is exponential growth… which says, that from the data outside China as March 6th, the number […]
Covid-19 – Day 126: Worldwide Clinical Trials of the Most Promising Treatments for Covid-19
(E) We just need one to work well, and asap! Reported in ScienceMag: “WHO launches global mega trial of the four most promising coronavirus treatments“. Treatments include: Remdesivir (antiviral – […]
COVID-19 – Day 126: How Professor Raoult at Mediterannee Infection will Treat COVID-19 Patients?
(E) Professor Didier Raoult and the Institut Hospitalo-Universitaire (IHU) de Marseille, who conducted early successful tests with the hydroxychloroquine and azithromycin as a treatment to Covid-19, have announced how they […]
COVID-19 – Day 125: FDA Approves Cepheid 45 mns SARS-Cov2 Test for Hospitals
(E) Cepheid, a company which provides automated molecular diagnostics through its GeneXpert® System for hospitals has announced a new test approved by the FDA for Covid-19 that can be performed […]
COVID-19 – Day 125: The Tip of the Iceberg from David Ho HIV Virologist Pioneer
(E) Caltech published a complete, clear, and concise summary of the conoravirus pandemic in a Q&A with David Ho, whose research has been key for the understanding of the HIV […]
COVID-19 – Day 124: Goldman Sachs 2nd Quater GDP Contracting by 24%
(E) CNBC reported the latest economic forecast of Goldman Sachs. Economists, at the financial firm, are forecasting a historically sharp and swift recession, with second-quarter GDP sinking a stunning 24% […]
COVID-19 – Day 123: Why Country is Flattening the Curve?
(E) The New York Times has published today which countries have been successful to flatten the curve? So far Singapore, Hong Kong, Taiwan, Korea, and China. Italy, Spain, Iran, France, […]
COVID-19 – Day 122: Sanofi Offers Anti-Malaria Treatment for COVID-19 after “Promising” Trials
(E) Sanofi said it could potentially treat COVID-19 patients with its anti-malarial drug Plaquenil after what it described as “promising” early test results. Sanofi said it was ready to work […]
COVID-19 – Day 122: La Musique de Renaud Capuçon pour Adoucir nos Moeurs
(E) Famous French cellist Gautier Capuçon was supposed to perform with MTT and the San Francisco Symphony orchestra several concerts from Tuesday to Saturday last week. But all those concerts […]
COVID-19 – Day 120: From Paris to San Francisco PLEASE STAY HOME!
(E) Seven counties of the San Francisco Bay Area have ordered nearly 7 million residents to shelter in place for the next three weeks as health officials scramble to keep […]
COVID-19 – Day 120: The Implications of Hitting the Hard 0% Interest Rate Floor
(E) If you want to understand how the economy works, listen to hedge fund manager Ray Dalio. Following Sunday’s announcement of the Federal Reserve, Mr. Dalio published today an article […]
COVID-19 – Day 120: First Trial of COVID-19 Vaccine with Humans
(E) It goes without saying that some of the best biotech firms and researchers are working no stop to find a vaccine against the COVID-19 virus. Today, Moderna ,a biotech […]
COVID-19 – Day 119: Testing, Testing, and Testing
(E) Business Insider has one chart that summarized how the US is behind many other countries in testing its population against the coronavirus: “One chart shows how many coronavirus tests […]
COVID-19 – Day 119: Why the Coronavirus Spread Exponentially, and how to “Flatten the Curve”?
(E) The Washington Post has a fantastic article that simulates how the coronavirus spreads exponentially in a population of 200 inhabitants, and why it is so important to slow its propagation: […]
COVID-19 – Day 119: Understanding the Coronavirus SARS-Cov-2
(E) The New Yorker has published a thorough interview – Understand the Novel Coronavirus – with Justin Lessler, an associate professor of epidemiology at the Johns Hopkins Bloomberg School of […]
Waymo (ChauffeurNet) versus Telsa (HydraNet)
(T) Following are some easy to understand summaries of how Waymo and Telsa are approaching the design, architectures, and modeling of their self-driving cars. Note how much they differ. Waymo […]
A Silicon Valley Insider 